SMAD2 and inflammatory bowel disease: The demonstration that Smad7 is over-expressed in IBD tissue concomitantly to the reduced TGF-β1/Smad2/3 signaling prompted us to mechanistically evaluate the involvement of Smad7 in the IBD-associated immune–inflammatory response.